Heron Therapeutics (HRTX)

Heron Therapeutics (HRTX) Income Statement


Heron Therapeutics Income Statement

Last quarter (Q4 2023), Heron Therapeutics's total revenue was $34.23M, an increase of 14.17% from the same quarter last year. In Q4, Heron Therapeutics's net income was $-10.72M. See Heron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 127.04M$ 127.04M$ 107.67M-$ 88.64M$ 145.97M
Cost of Revenue
$ 65.11M$ 65.11M$ 54.87M$ 46.02M$ 36.19M$ 61.62M
Gross Profit
$ 61.94M$ 61.94M$ 52.80M$ -46.02M$ 52.45M$ 84.35M
Operating Expense
$ 172.55M$ 172.55M$ 227.46M$ 258.15M$ 280.61M$ 295.04M
Operating Income
$ -110.61M$ -110.61M$ -174.66M$ -304.17M$ -228.16M$ -210.69M
Net Non Operating Interest Income Expense
$ -504.00K$ -504.00K$ -836.00K$ -1.98M$ 1.73M$ 5.79M
Other Income Expense
$ -560.00K$ -560.00K$ 6.53M$ -85.47M$ -847.00K$ 158.00K
Pretax Income
$ -110.56M$ -110.56M$ -182.02M$ -220.68M$ -227.28M$ -204.75M
Tax Provision
$ -1.46M$ -1.46M$ -13.90M$ -1.19M--
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -110.59M$ -110.56M$ -182.02M$ -220.68M$ -227.28M$ -204.75M
Basic EPS
$ -0.85$ -0.80$ -1.67$ -2.24$ -2.50$ -2.50
Diluted EPS
$ -0.85$ -0.80$ -1.67$ -2.24$ -2.50$ -2.50
Basic Average Shares
$ 552.54M$ 138.13M$ 108.88K$ 98.47K$ 90.77M$ 81.78M
Diluted Average Shares
$ 552.54M$ 138.13M$ 108.88K$ 98.47K$ 90.77M$ 81.78M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 237.66M$ 237.66M$ 282.33M$ 304.17M$ 316.80M$ 356.66M
Net Income From Continuing And Discontinued Operation
$ -110.56M$ -110.56M$ -182.00M$ -220.68M$ -227.28M$ -204.75M
Normalized Income
$ -65.17M$ -112.02M$ -195.92M-$ -227.28M$ -204.75M
Interest Expense
----$ 1.90M$ 1.47M
$ -106.69M$ -106.69M$ -179.55M$ -218.27M$ -225.38M$ -203.28M
$ -105.19M$ -105.19M$ -177.18M$ -214.04M$ -222.53M$ -201.23M
Currency in USD

Heron Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis